STACY FUSNER: Open Payments
NPI 1720690597 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 47 payments from 12 companies in 2025. Trend: 2023 $797 · 2024 $717 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $115 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Novo Nordisk Inc | 5 | $85 |
| Amgen Inc. | 5 | $84 |
| Phathom Pharmaceuticals, Inc. | 2 | $48 |
| Corcept Therapeutics | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| QOL Medical, LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $20 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, UBRELVY, Wegovy, VOQUEZNA, OTEZLA, Korlym.
Industry payments across OH — which companies pay providers there.
